DK472083D0 - Fremgangsmade til fremstilling af modificerede stammer af viral kvaeg-diarrevirus - Google Patents

Fremgangsmade til fremstilling af modificerede stammer af viral kvaeg-diarrevirus

Info

Publication number
DK472083D0
DK472083D0 DK4720/83A DK472083A DK472083D0 DK 472083 D0 DK472083 D0 DK 472083D0 DK 4720/83 A DK4720/83 A DK 4720/83A DK 472083 A DK472083 A DK 472083A DK 472083 D0 DK472083 D0 DK 472083D0
Authority
DK
Denmark
Prior art keywords
virus
revirus
kvaeg
diar
viral
Prior art date
Application number
DK4720/83A
Other languages
English (en)
Other versions
DK170061B1 (da
DK472083A (da
Inventor
Jean-Claude Delgoffe
Michele Lobmann
Nathan Zygraich
Original Assignee
Smith Kline Rit
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline Rit filed Critical Smith Kline Rit
Publication of DK472083D0 publication Critical patent/DK472083D0/da
Publication of DK472083A publication Critical patent/DK472083A/da
Application granted granted Critical
Publication of DK170061B1 publication Critical patent/DK170061B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
    • C12N2760/18534—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
    • C12N2770/24334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
    • C12N2770/24361—Methods of inactivation or attenuation
    • C12N2770/24363—Methods of inactivation or attenuation by chemical treatment
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/813—Viral vaccine for bovine species, e.g. cattle
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/821—Drug, bio-affecting and body treating compositions involving temperature-sensitive mutant virus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Compounds Of Unknown Constitution (AREA)
DK472083A 1982-10-13 1983-10-13 Fremgangsmåde til fremstilling af modificerede stammer af viral kvægdiarrevirus samt fremgangsmåde til fremstilling af en vaccine mod infektion med viral kvægdiarrevirus DK170061B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/434,155 US4618493A (en) 1982-10-13 1982-10-13 Temperature sensitive strains of bovine viral diarrhoea virus, preparation thereof and vaccines containing them
US43415582 1982-10-13

Publications (3)

Publication Number Publication Date
DK472083D0 true DK472083D0 (da) 1983-10-13
DK472083A DK472083A (da) 1984-04-14
DK170061B1 DK170061B1 (da) 1995-05-15

Family

ID=23723042

Family Applications (1)

Application Number Title Priority Date Filing Date
DK472083A DK170061B1 (da) 1982-10-13 1983-10-13 Fremgangsmåde til fremstilling af modificerede stammer af viral kvægdiarrevirus samt fremgangsmåde til fremstilling af en vaccine mod infektion med viral kvægdiarrevirus

Country Status (16)

Country Link
US (1) US4618493A (da)
EP (1) EP0106831B1 (da)
JP (3) JPS5989631A (da)
AT (1) ATE48948T1 (da)
AU (1) AU572050B2 (da)
CA (1) CA1216234A (da)
DE (1) DE3381005D1 (da)
DK (1) DK170061B1 (da)
ES (2) ES8504929A1 (da)
FI (1) FI82264C (da)
GR (1) GR78966B (da)
IE (1) IE56438B1 (da)
NO (1) NO166953C (da)
NZ (1) NZ205491A (da)
PT (1) PT77454B (da)
ZA (1) ZA837573B (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6291228B1 (en) 1988-08-03 2001-09-18 Vericore Limited Vaccine

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3052606A (en) * 1958-08-30 1962-09-04 Behringwerke Ag Viral mutation with nitrites
US3293129A (en) * 1962-02-01 1966-12-20 Cornell Res Foundation Inc Immunization of cattle against virus diarrhea virus
US3629413A (en) * 1970-02-04 1971-12-21 Univ Southern Illinois Polyvalent bovine vaccines and methods of making and using same
US3907986A (en) * 1972-12-18 1975-09-23 Rit Rech Ind Therapeut Live attenuated infectious bovine rhinotracheitis virus vaccines and preparation thereof
GB1390467A (en) * 1973-03-30 1975-04-16 Rit Rech Ind Therapeut Vaccination method using temperature sensitive virus mutants
US3927208A (en) * 1973-05-14 1975-12-16 Rit Rech Ind Therapeut Live bovine adenovirus vaccines, preparation thereof and method of vaccination using them
US3962424A (en) * 1974-01-31 1976-06-08 Recherche Et Industrie Therapeutiques (R.I.T.) Live brovine adenovirus vaccines, preparation thereof and method of vaccination using them
US4053583A (en) * 1976-03-01 1977-10-11 Smithkline Corporation Live newcastle disease virus vaccines
JPS5817084B2 (ja) * 1978-08-25 1983-04-05 新明和工業株式会社 塵芥押込処理装置の操作装置

Also Published As

Publication number Publication date
JPS5989631A (ja) 1984-05-23
AU572050B2 (en) 1988-04-28
NO833717L (no) 1984-04-16
ES526382A0 (es) 1985-10-01
NO166953C (no) 1991-09-18
ATE48948T1 (de) 1990-01-15
PT77454B (en) 1986-02-26
US4618493A (en) 1986-10-21
JPH0773493B2 (ja) 1995-08-09
JPH05192139A (ja) 1993-08-03
PT77454A (en) 1983-11-01
EP0106831A2 (fr) 1984-04-25
CA1216234A (en) 1987-01-06
ES8600058A1 (es) 1985-10-01
DK170061B1 (da) 1995-05-15
AU1852983A (en) 1984-04-19
JPH05176764A (ja) 1993-07-20
ZA837573B (en) 1984-08-29
IE56438B1 (en) 1991-07-31
DE3381005D1 (de) 1990-02-01
IE832400L (en) 1984-04-13
GR78966B (da) 1984-10-02
FI82264B (fi) 1990-10-31
FI82264C (fi) 1991-02-11
NZ205491A (en) 1989-07-27
FI833717A0 (fi) 1983-10-12
NO166953B (no) 1991-06-10
EP0106831A3 (en) 1986-01-22
ES526380A0 (es) 1985-04-16
DK472083A (da) 1984-04-14
FI833717A (fi) 1984-04-14
ES8504929A1 (es) 1985-04-16
EP0106831B1 (fr) 1989-12-27
JPH0463862B2 (da) 1992-10-13
JPH0773494B2 (ja) 1995-08-09

Similar Documents

Publication Publication Date Title
Zygraich et al. In vivo and in vitro properties of a temperature sensitive mutant of infectious bovine rhinotracheitis virus
LU90203I2 (fr) Anatoxine diphtérique anatoxine tétanique trois antigènes coquelucheux purifiés (toxine pertussique tp hémagglutinine filamenteuse (haf) et pertactine (protéine de membrane externe 69 kd) et le principal antigène de surface du virus de l'hépatite b (vhb) purfié (infanrix hepb) et ses dérivés pharmaceutiquement acceptables
ATE20309T1 (de) Pharmazeutische zubereitung.
US3927208A (en) Live bovine adenovirus vaccines, preparation thereof and method of vaccination using them
ES486442A0 (es) Un metodo de preparar una vacuna que contiene una cepa ate- nuada de virus de peritonitis infecciosa felina.
DK472083D0 (da) Fremgangsmade til fremstilling af modificerede stammer af viral kvaeg-diarrevirus
GB1413614A (en) Virus production
JPS6456620A (en) Production of hemorrhagic fever with renal syndrome virus antigen and vaccine and diagnostic agent using said antigen
KR840001515B1 (ko) 백신의 제조방법
DK257887A (da) Fremgangsmaade til fremstilling af hbcag i gaer og plasmid til brug ved udoevelse af fremgangsmaaden
RU92006181A (ru) Аттенуированный холодоадаптированный штамм вируса гриппа в/ссср/60/69 для получения живой интраназальной гриппозной вакцины
Fribourg-Blanc et al. Congenital Syphilis
Krugman Live attenuated measles vaccine: Its development and characteristics.
GB1105178A (en) Improvements in or relating to antigens suitable for the diagnosis of hepatitis
Felfe et al. Trends in production of foot-and-mouth disease vaccine.
JPS56115724A (en) Prophilaxis and remedy for avian infectious coryza
Géresi et al. The ontogenic development of antitoxin-producing capacity of humans and animals-- The immuno-modulation in immunization practice.
GB871838A (en) Purification of poliomyelitis virus
GB1131931A (en) Improvements in and relating to vaccines
KR930013114A (ko) 바이러스 벡터를 이용한 경구용 b형 간염백신의 제조방법

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed

Country of ref document: DK